DOCSLIB.ORG

Utility of Esmolol in Thyroid Crisis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Utility of Esmolol in Thyroid Crisis UTILITY OF ESMOLOL IN THYROID CRISIS Jasleen Duggal1, Sarabjeet Singh1, Paulina Kuchinic2, Paula Butler1, Rohit Arora1 1Department of Medicine, Chicago Medical School (C.M.S.) Chicago, IL (USA), 2Department of Emergency Medicine, Chicago Medical School (C.M.S.) Chicago, IL (USA) Corresponding Author: [email protected] _____________________________________________________________________________________ ABSTRACT Thyroid storm is an uncommon but potentially life-threatening manifestation of hyperthyroidism. Mortality can be 30-60% in hospitalized patients unless appropriately treated by combined therapy. We report a case of a 25-year-old African American woman with past medical history of Graves disease and moderately persistent asthma who presented to the emergency department with signs and symptoms of thyrotoxic crisis. Therapy instituted and included the use of an esmolol infusion for control of hypersympathetic activity. A review of the clinical presentation, diagnosis, and management of thyrotoxic crisis is presented along with a discussion on the choice of beta blockade therapy. Key Words: Thyroid storm, thyroid crisis, esmolol, beta blockers _____________________________________________________________________________________ hyroid storm is an uncommon but life- Physical examination revealed a tremulous, anxious Tthreatening manifestation of hyperthyroidism, woman in severe distress. Skin was moist. She had which, unless appropriately treated by combined no exophthalmos. The thyroid gland was therapy, causes 30-60% of deaths in hospitalized diffusely enlarged, firm, smooth, and non- patients.1 Propranolol has been previously tender with a bruit. Cardiac systolic murmur recommended for immediate control of the (2/6) was audible in the apex. sympathetic hyperactivity.3 The remainder of the physical examination We report our experience with a case of was unremarkable. A 12 lead electrocardiogram thyroid crisis secondary to noncompliance with done at the time of admission revealed a the medications. A review of the literature supraventricular tachycardia. Her chest indicated the use of esmolol for acute thyrotoxic roentgenogram was normal with no evidence of crisis.4 cardiomegaly or pulmonary congestion. The patient was placed on a cardiac monitor and an Case Report intravenous catheter was inserted. Urgent thyroid A 25-year-old African American woman with past function testing revealed thyroid-stimulating medical history of Graves disease and asthma hormone (TSH) undetectable, free thyroxine at (moderately persistent) presented to our 4.45 ng/dl (normal 0.58-1.64 ng/dl), and emergency department with restlessness, triiodothyronine at 22.82 (normal 2.5-3.9 pg/ml) palpitations, dyspnea, and diaphoresis. She was levels markedly elevated. All other laboratory not compliant with her medications and denied tests including cardiac enzymes and basal exogenous iodine ingestion. The patient did not natriuretic peptide (BNP) were normal. smoke cigarettes or drink alcohol, and denied Thyrotoxic crisis was diagnosed and esmolol illicit drug use. infusion, oral propylthiouracil, saturated solution For a few days before her admission she of potassium iodide, and intravenous experienced fever and diarrhea. Initial vital signs were hydrocortisone was initiated in the emergency temperature, 37.2C (99F); blood pressure, 170/96 department. Esmolol was given with a loading mm Hg; pulse rate, 180 beats / minute and regular; dose of 500 mcg /kg over 1 minute; followed with and respiratory rate, 36 times / minute. a dose of 50-mcg/kg/minute. As the response was Can J Clin Pharmacol Vol 13(3) Fall 2006:e292-e295; November 26, 2006 e292 © 2006 Canadian Society for Clinical Pharmacology. All rights reserved. Utility of esmolol in thyroid crisis inadequate, it was titrated upward in 50 includes overwhelming sepsis, central nervous mcg/kg/minute increments (increased no more symptom infection, anticholinergic or adrenergic frequently than every 4 minutes) to a maximum of intoxication, other endocrine dysfunction, and 200 mcg/kg/minute. The patient was transferred to psychiatric illness. Timely clinical diagnosis the intensive care unit (ICU) for further care. Her depends on obtaining a history of previously heart rate decreased to 90 beats/minute and all existing hyperthyroidism, the presence of enlarged symptoms subsequently resolved. The infusion on thyroid and high index of suspicion. Our patient the above rate was continued for 10 hours and the had all the three above-mentioned parameters to patient was monitored for hemodynamic stability. make the diagnosis of thyroid storm. Treatment of As there was no complication observed, the thyrotoxic crisis should begin immediately after infusion rate was reduced by 50% 30 minutes diagnosis. following the first dose of 100 mg oral Treatment is aimed at blocking the metoprolol. Following the second dose of peripheral effect of thyroid hormone, inhibiting metoprolol, control was adequate for the first 2 the hormone synthesis and release, and preventing hours and esmolol was discontinued. the peripheral conversion of T4 to T3. PTU, 300 Endocrinology consultation was obtained. It mg, can be administered orally or by nasogastric was believed that the thyrotoxic crisis was tube. Propylthiouracil prevents the synthesis of secondary to Graves disease. After stabilization thyroid hormone and inhibits the peripheral the patient was discharged home on metoprolol conversion of T4 to T3. Major side effects of PTU and propylthiouracil with a scheduled follow up include skin rashes, fever, diarrhea, hepatitis, appointment for the next week. arthralgias, and salivary gland swelling; rarely agranulocytosis occurs. PTU, 300 mg, can be DISCUSSION given three to four times a day. Hydrocortisone reduces T4-to-T3 conversion, and may have a Thyrotoxic crisis is an uncommon clinical entity, direct effect on the underlying autoimmune occurring in a small fraction of those patients that process if the thyroid storm is due to Graves are hyperthyroid. It is hypothesized that thyroid disease. Hydrocortisone improved outcomes in at hormones increase the density of βreceptors and least one series7 and it is reasonable to administer cyclic adenosine monophosphate and decrease the hydrocortisone 100 mg intravenously every eight density of αreceptors.5 Plasma levels and the hours in patients. Iodide inhibits hormone release, urinary excretion rates of epinephrine and nor- but should not be given until at least 1 hour after epinephrine are normal in thyrotoxic patients.6 PTU has been given. Potassium iodide (SSKI), 3 The causes of thyrotoxic crisis include Graves to 5 drops every 8 hours orally can be used. disease, toxic multinodular goiter, toxic nodule, The most important aspect in treating Hashimoto’s thyroiditis, deQuevain’s thyroiditis, thyrotoxic crisis involves blocking the peripheral metastatic follicular thyroid carcinoma, TSH- effects of thyroid hormone. The cardiovascular producing tumors, and factitious hyperthyroidism. manifestations of thyrotoxic crisis can be severe, The most common etiology for thyrotoxic crisis is and include tachyarrythmias, chest pain, and Graves disease (toxic diffuse goiter). dyspnea. Congestive heart failure (CHF) occurs in The clinical presentation of thyrotoxic crisis 50% of cases.8 Thyrotoxicosis is associated with is variable. The most common symptoms include both reversible and irreversible cardiomyopathy, weight loss, shortness of breadth, palpitations, although the cause is uncertain.9 Increased oxygen chest pain, nervousness, anxiety, altered mental demand may cause myocardial ischemia. This was status, and gastrointestinal complaints. The most unlikely in our patient as she had normal cardiac common signs of thyrotoxicosis include fever, enzymes. tachycardia, tremor, altered mental status, and an The cardiac manifestations of thyrotoxic enlarged thyroid gland. T3, T4, and FT4 levels crisis can be life threatening and demand will usually confirm the diagnosis of immediate therapy. Propranolol has traditionally hyperthyroidism. However, therapy for thyrotoxic been the drug of choice for blocking the crisis cannot wait for thyroid function tests to peripheral effects.3 However, there are several return. The differential diagnosis of thyroid storm limitations associated with the use of propranolol. e293 Can J Clin Pharmacol Vol 13(3) Fall 2006:e292-e295; November 26, 2006 © 2006 Canadian Society for Clinical Pharmacology. All rights reserved. Utility of esmolol in thyroid crisis In the setting of CHF administration of Acknowledgements propranolol can be dangerous by inducing There was no financial support received to carry cardiovascular collapse.8 Treatment failure in out the above study. There has been no thyrotoxic crisis has occurred with the use of commercial or proprietary interest in any drug, propranolol.10 device, or equipment mentioned in the submitted There are several potential advantages of article. Institutional Review Board approval was esmolol over propranolol in the setting of obtained. thyrotoxic crisis. Although the onset of action of intravenous propranolol and esmolol is similar, their elimination half-life (t1/2) and duration are REFERENCES markedly different. The t1/2 α and β for propranolol are 10 minutes and 2.3 hours 1. Trasciatti S, Prete C, Palummeri E, et al. respectively, while the t1/2 αand βfor esmolol Thyroid storm as precipitating factor in onset of coma in an elderly woman: case report and are 2 minutes and 9 minutes, respectively.11 In one literature
Load more

Recommended publications
  • Use of Intravenous Esmolol to Predict Efficacy of Oral Beta-Adrenergic Blocker Therapy in Patients with Neurocardiogenic Syncope
    402 JACC Vol. 19, No. 2 February 1992:402-8 REPORTS ON THERAPY Use of Intravenous Esmolol to Predict Efficacy of Oral Beta­ Adrenergic Blocker Therapy in Patients With Neurocardiogenic Syncope JASBIR S. SRA, MD, VISHNUBHAKTA S. MURTHY, MD, PHD, MOHAMMAD R. JAZAYERI, MD, FACC, YUE-HUA SHEN, MD, PAUL J. TROUP, MD, FACC, BOAZ AVITALL, MD, PHD, MASOOD AKHTAR, MD, FACC Milwaukee, Wisconsin The usefulness of esmolol in predicting the efficacy of treatment Irrespective of their response to esmolol infusion, all patients with an oral beta-adrenergic blocking agent was evaluated in 27 had a follow-up tilt test with oral metoprolol after an interval of consecutive patients with neurocardiogenic syncope. Seventeen ~5 half-lives of the drug. All 16 patients (100%) with a negative patients had a positive head-up tilt test response at baseline and 10 tilt test response during esmolol infusion had a negative tilt test patients required intravenous isoproterenol for provocation of response with oral metoprolol. Of the 11 patients with a positive hypotension. All patients were then given a continuous esmolol tilt test response during esmolol infusion, 10 (90%) continued to infusion (500 JLg/kg per min loading dose for 3 min followed by have a positive response with oral metoprolol. 300 Jlg/kg per min maintenance dose) and rechallenged with a It is concluded that in the electrophysiology laboratory, es­ head-up tilt test at baseline or with isoproterenol. molol can accurately predict the outcome of a head-up tilt Of the 17 patients with a positive baseline tilt test response, 11 response to oral metoprolol.
    [Show full text]
  • Esmolol Hydrochloride 10 Mg/Ml Solution for Injection Esmolol Hydrochloride
    Package leaflet: Information for the patient Esmolol hydrochloride 10 mg/ml solution for injection Esmolol hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important information for you. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or nurse. – This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. – If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Esmolol hydrochloride 10 mg/ml solution for injection is and what it is used for 2. What you need to know before you use Esmolol hydrochloride 10 mg/ml solution for injection 3. How to use Esmolol hydrochloride 10 mg/ml solution for injection 4. Possible side effects 5. How to store Esmolol hydrochloride 10 mg/ml solution for injection 6. Contents of the pack and other information 1. What Esmolol hydrochloride 10 mg/ml chlor promazine, used to treat mental dis - solution for injection is and what it is orders) used for – Clozapine which is used to treat mental Esmolol hydrochloride 10 mg/ml belongs to the disorders group of beta-blockers. These medicines slow – Epinephrine, which is used to treat allergic down the heartbeat and reduce blood pressure. reactions – Medicines used to treat asthma Esmolol hydrochloride 10 mg/ml is used for – Medicines used to treat colds or a blocked short-term treatment if your heart beats too nose, called nasal “decongestants” fast.
    [Show full text]
  • Thyroid Disease Update
    10/11/2017 Thyroid Disease Update • Donald Eagerton M.D. Disclosures I have served as a clinical investigator and/or speakers bureau member for the following: Abbott, Astra Zenica, BMS, Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Novo Nordisk, Pfizer, and Sanofi Aventis Thyroid Disease Update • Hypothyroidism • Hyperthyroidism • Thyroid Nodules • Thyroid Cancer 1 10/11/2017 2 10/11/2017 Case 1 • 50 year old white female is seen for follow up. Notices cold intolerance, dry skin, and some fatigue. Cholesterol is higher than prior visits. • Family history; Mother had history of hypothyroidism. Sister has hypothyroidism. • TSH = 14 (0.30- 3.3) Free T4 = 1.0 (0.95- 1.45) • Weight 70 kg Case 1 • Next step should be • A. Check Free T3 • B. Check AntiMicrosomal Antibodies • C. Start Levothyroxine 112 mcg daily • D. Start Armour Thyroid 30 mg q day • E. Check Thyroid Ultrasound Case 1 Next step should be • A. Check Free T3 • B. Check AntiMicrosomal Antibodies • C. Start Levothyroxine 112 mcg daily • D. Start Armour Thyroid 30 mg q day • E. Check Thyroid Ultrasound 3 10/11/2017 Hypothyroidism • Incidence 0.1- 2.0 % of the population • Subclinical hypothyroidism in 4-10% of the adult population • 5-8 times higher in women An FT4 test can confirm hypothyroidism 13 • In the presence of high TSH and FT4 levels in relation to the thyroid function TSH, low FT4 (free thyroxine) usually signalsTSH primary hypothyroidism12 Overt Mild Mild Overt Euthyroidism FT4 Hypothyroidism Thyrotoxicosis* Thyrotoxicosis vs. hyperthyroidism¹ While these terms are often used interchangeably, thyrotoxicosis (toxic thyroid), describes presence of too much thyroid hormone, whether caused by thyroid overproduction (hyperthyroidism); by leakage of thyroid hormone into the bloodstream (thyroiditis); or by taking too much thyroid hormone medication.
    [Show full text]
  • Keeping up with the Pace of Antiarrhythmic Drugs ANNMARIE PALATNIK, APN,BC, MSN Coordinator of Continuing Education • Virtua Health • Marlton, N.J
    D rug File Keeping up with the pace of antiarrhythmic drugs ANNMARIE PALATNIK, APN,BC, MSN Coordinator of Continuing Education • Virtua Health • Marlton, N.J. HAVE YOU NOTICED how challenging it is to Conducting impulses keep pace with the The conduction system of the heart, shown below, begins with the heart’s natural pacemaker, the changing beat of phar- sinoatrial (SA) node. When an impulse leaves the SA node, it travels through the atria along macology? Just as you Bachmann’s bundle and the internodal pathways on its way to the atrioventricular (AV) node. After learn the latest drugs the impulse passes through the AV node, it travels to the ventricles, first down the bundle of His, and classifications, new then along the bundle branches and, finally, down the Purkinje fibers. classes are developed and new drugs added to Bachmann’s bundle classes. Even drugs that have been on the mar- ket a long time can have dosing and indica- SA node tion changes. Antiarrhythmic Internodal tracts drugs, which restore Posterior (Thorel’s) normal rhythm and Middle (Wenckebach’s) conduction to the heart, Anterior are no exception. In this AV node article, I’ll bring you up-to-date on the Bundle of His antiarrhythmics now Right bundle branch available. Left bundle branch Class assignments Most antiarrhythmic drugs used to slow a rapid heart rate are classified according to the Vaughn Williams classification system Purkinje fibers (see Classifying Anti- arrhythmics the Vaughn Williams way). These drugs fall Class I into four general groups in this classification system Sodium channel blockers stop the flow of sodium into with each group having several subgroups.
    [Show full text]
  • Comparative Study of IV Esmolol, IV Diltiazem, and IV Lignocaine Hydrochloride in Attenuating Pressure Response to Laryngoscopy and Intubation
    Jemds.com Original Research Article Comparative Study of IV Esmolol, IV Diltiazem, and IV Lignocaine Hydrochloride in Attenuating Pressure Response to Laryngoscopy and Intubation Sathya Narayanan Karunanithi1, Geeta Bhandari2, Kedar Singh Shahi3, Aditya Kumar Chauhan4, Pooja Gautam5 1Department of Anaesthesiology, Critical Care, Pain and Palliative Medicine Government Medical College, Haldwani, Uttarakhand, India. 2 Department of Anaesthesiology, Critical Care, Pain and Palliative Medicine Government Medical College, Haldwani, Uttarakhand, India. 3Department of Surgery, Government Medical College, Haldwani, Uttarakhand, India. 4Department of Anaesthesiology, Critical Care, Pain and Palliative Medicine Government Medical College, Haldwani, Uttarakhand, India. 5Department of Anaesthesiology, Critical Care, Pain and Palliative Medicine Government Medical College, Haldwani, Uttarakhand, India. ABSTRACT BACKGROUND Not many studies have compared more than two drugs in attenuating pressor Corresponding Author: responses to laryngoscopy and intubation. This study compares four groups of Dr. Geeta Bhandari, considerable size. The present study compared intravenous esmolol, diltiazem, and Professor and HOD, Department of Anaesthesiology, lignocaine, for their efficacy to abate pressure response to laryngoscopy and Critical Care, Pain and Palliative Medicine, intubation. Government Medical College, Haldwani-263139, Uttarakhand, India. METHODS E-mail: [email protected] This is a prospective, randomized, double-blinded, controlled clinical study conducted among 220 patients of ASA grade I/II (age 18–60 years), undergoing DOI: 10.14260/jemds/2020/447 elective surgical procedure requiring general anaesthesia with endotracheal intubation over a period of 15 months at a tertiary hospital setup. Study subjects How to Cite This Article: were categorised as Groups D, E, L, and N that received diltiazem (0.2 mg/Kg IV), Karunanithi SN, Bhandari G, Shahi KS, et esmolol (2 mg/Kg IV), lignocaine (1.5 mg/Kg IV), and normal saline, respectively; al.
    [Show full text]
  • Atrial Fibrillation in the Surgical Patient
    DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care practices based upon the available medical literature and clinical expertise at the time of development. They should not be considered to be accepted protocol or policy, nor are intended to replace clinical judgment or dictate care of individual patients. NEW ONSET ATRIAL FIBRILLATION IN THE SURGICAL PATIENT SUMMARY Atrial fibrillation is a common postoperative arrhythmia and can represent a major source of morbidity and mortality. Treatment of atrial fibrillation is directed at three main objectives: controlling the ventricular response, preventing thromboembolism, and maintaining sinus rhythm. Therapeutic decisions also hinge on patients’ hemodynamic stability. In patients who are hemodynamically unstable, direct current cardioversion is the first line therapy and pharmacotherapy should be used as adjunctive treatment. In patients who are hemodynamically stable, pharmacologic treatment including class II (beta-blockers), class III (amiodarone), or class IV (nondihydropyridine calcium channel blockers) agents are viable options. RECOMMENDATIONS Level 1 Beta-blockade (esmolol or metoprolol), nondihydropyridine calcium channel blockers (diltiazem or verapamil), and amiodarone are pharmacologic options to manage new onset atrial fibrillation (see table for dosing). Beta-blockers are the first line therapy for postoperative atrial fibrillation to achieve rapid ventricular rate control and conversion to sinus rhythm. Diltiazem is second line rate control agent when beta-blocker therapy has failed. Both therapies should be avoided in hypotensive patients. Amiodarone can provide both rate and rhythm control and is an alternative therapy to beta-blockade for postoperative atrial fibrillation especially when the patient is hemodynamically unstable or has a known ejection fraction of < 40%.
    [Show full text]
  • Marrakesh Agreement Establishing the World Trade Organization
    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
    [Show full text]
  • Endocrine Emergencies
    Endocrine Emergencies • Neuroendocrine response to Critical illness • Thyroid storm/Myxedema Coma • Adrenal Crisis/Sepsis • Hyper/Hypocalcemia • Hypoglycemia • Hyper and Hyponatremia • Pheochromocytoma crises CASE 76 year old man presents with urosepsis and is Admitted to MICU. He has chronic renal insufficiency. During his hospital course, he is intubated and treated With dopamine. Thyroid studies are performed for Inability to wean from ventilator. What labs do you want? Assessment of Thyroid Function • Hormone Levels: Total T4, Total T3 • Binding proteins: TBG, (T3*) Resin uptake • Free Hormone Levels: TSH, F T4, F T3, Free Thyroid Index, F T4 by Eq Dialysis • Radioactive Iodine uptake (RAIU); primarily for DDx of hyperthyroidism • Thyroid antibodies; TPO, Anti-Thyroglobulin, Thyroid stimulating immunoglobulins, Th receptor antibodies Labs: T4 2.4 ug/dl (5-12) T3U 40% (25-35) FTI 1.0 (1.2-4.2) FT4 0.6 (0.8-1.8) TSH 0.2 uU/ml (.4-5.0) Non-thyroidal illness • Hypothesis: NTI vs 2° Hypothyroidism –RT3 ↑ in NTI and ↓ in Hypothyroidism • Hypothesis: NTI vs Hyperthyroidism – TT3 ↓ in NTI and in ↑ Hyperthyroidism • 75 year old woman with history of hypothyroidism is found unresponsive in her home during a cold spell in houston. No heat in the home. • Exam: T° 95, BP 100/60, P 50, RR 8 • Periorbital edema, neck scar, no rub or gallop, distant heart sounds, crackles at bases, peripheral edema • ECG: Decreased voltage, runs of Torsade de pointes • Labs? Imaging? • CXR: cardiomegaly • Glucose 50 • Na+ 120, K+ 4, Cl 80, HCO3¯ 30 • BUN 30 Creat 1.4 • ABG: pH 7.25, PCO2 75, PO2 80 • CK 600 • Thyroid studies pending • Management: Manifestations of Myxedema Coma • Precipitated by infection, iatrogenic (surgery, sedation, diuretics) • Low thyroid studies • Hypothermia • Altered mental status • Hyponatremia • ↑pCO2 • ↑CK • ↑Catecholamines with ↑vascular resistance • Cardiac: low voltage, Pericardial effusion, impaired relaxation with ↓C.O.
    [Show full text]
  • Thyrotoxic Crisis
    THYROTOXIC CRISIS INTRODUCTION (KATRINA KNAPP, D.O., 4/2016) Thyrotoxicosis is the clinical manifestation of hyperthyroidism. Thyrotoxic crisis, otherwise known as thyroid storm, is a life threatening condition that involves multi-organ system dysfunction including severe cardiovascular, thermoregulatory, gastrointestinal, and neurobehavioral symptoms. It is seen in less than 1% of adults with hyperthyroidism and is rarer in children. It has a high mortality rate (10-30%) if not recognized early and treated aggressively. PATHOPHYSIOLOGY Thyroid hormones are produced in the thyroid gland under the influence of thyroid stimulating hormone (TSH). Thyroid releasing hormone (TRH) from the hypothalamus stimulates TSH release from the pituitary. In order to maintain thyroid hormone levels in normal range, circulating levels of thyroid hormones exert feedback inhibition on the hypothalamus and pituitary axis (HPA). There are 2 active thyroid hormones: triiodothyronine (T3) and L-thyroxine (T4). T4 is exclusively made in the thyroid gland. T3 is also made in the thyroid but 80% is made in the peripheral tissues by de-iodination of T4. Iodine is essential for thyroid hormone synthesis. T4 is more abundant than T3 and a greater proportion is protein bound (e.g. TBG, thyroid binding globulin). Only 0.03% of T4 is unbound. It is the unbound (“free”) hormones that are active. A greater proportion of T3 is the free form, and has a greater affinity (10 fold) for tissue thyroid hormone receptors than T4. T4 can also be metabolized to reverse T3 which is completely inactive. Most of the biologic activity of thyroid hormones is due to T3, but it is less reliably identified which is why we typically measure free T4.
    [Show full text]
  • Recurrent Concurrent Diabetic Ketoacidosis and Thyroid Storm
    Open Access Case Report DOI: 10.7759/cureus.14273 Recurrent Concurrent Diabetic Ketoacidosis and Thyroid Storm David F. Crudo 1 , Elizabeth T. Walsh 1 , Janel D. Hunter 1 1. Pediatric Endocrinology, Wake Forest University School of Medicine, Winston-Salem, USA Corresponding author: David F. Crudo, [email protected] Abstract Diabetic ketoacidosis (DKA) and thyroid storm are serious complications of underlying disease states. Either condition can induce the other, and the co-occurrence of these conditions is uncommon. We present the case of an adolescent patient with type 1 diabetes and autoimmune hypothyroidism who developed recurrent concurrent DKA and thyroid storm twice in an eight-month period. The simultaneous development of DKA and thyroid storm is uncommon with only 28 cases previously reported. Co- presentation of these two life-threatening conditions occurs in people with either preexisting diabetes, thyroid disease, or both. The purported pathophysiology of how DKA and thyroid storm affect the other is discussed. Categories: Endocrinology/Diabetes/Metabolism Keywords: diabetic ketoacidosis, thyroid storm, thyrotoxicosis, autoimmune thyroid disease Introduction Diabetic ketoacidosis (DKA) is a serious life-threatening complication of diabetes mellitus in which severe insulin deficiency leads to hyperglycemia, metabolic acidosis, dehydration, and electrolyte imbalances. The initial onset of diabetes, omissions in insulin therapy, and infections are common triggering factors [1]. Thyroid storm is an acute complication of hyperthyroidism typically precipitated by uncontrolled hyperthyroidism, discontinuation of antithyroid drugs, surgery, infection, trauma, or metabolic derangements [2]. DKA can be induced by thyroid storm and vice versa [3]. Although the co-occurrence of these entities is uncommon, each is potentially life-threatening without prompt recognition and appropriate therapy.
    [Show full text]
  • Thyroid Emergencies
    REVIEW ARTICLE Thyroid emergencies Dorina Ylli1, Joanna Klubo ‑Gwiezdzinska2, Leonard Wartofsky3,4 1 Endocrinology Division, University of Medicine, Tirana, Albania 2 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States 3 Endocrinology Division, Department of Medicine, Georgetown University School of Medicine, Washington DC, United States 4 MedStar Health Research Institute, MedStar Washington Hospital Center, Washington DC, United states KEY WORDS ABSTRACT coma, critical care, Myxedema coma and thyroid storm are among the most common endocrine emergencies presenting to hypothermia, general hospitals. Myxedema coma represents the most extreme, life ‑threatening expression of severe hypothyroidism, hypothyroidism, with patients showing deteriorating mental status, hypothermia, and multiple organ thyrotoxicosis system abnormalities. It typically appears in patients with preexisting hypothyroidism via a common pathway of respiratory decompensation with carbon dioxide narcosis leading to coma. Without early and appropriate therapy, the outcome is often fatal. The diagnosis is based on history and physical find‑ ings at presentation and not on any objective thyroid laboratory test. Clinically based scoring systems have been proposed to aid in the diagnosis. While it is a relatively rare syndrome, the typical patient is an elderly woman (thyroid hypofunction being much more common in women) who may or may not have a history of previously diagnosed or treated thyroid dysfunction. Thyrotoxic storm or thyroid crisis is also a rare condition, established on the basis of a clinical diagnosis. The diagnosis is based on the pres‑ ence of severe hyperthyroidism accompanied by elements of systemic decompensation. Considering that mortality is high without aggressive treatment, therapy must be initiated as early as possible in a critical care setting.
    [Show full text]
  • Thyroid Emergencies
    The Art and Science of Infusion Nursing Angela M. Leung , MD, MSc Thyroid Emergencies cal manifestations, diagnostic methods, and treatments of ABSTRACT hypothyroidism and hyperthyroidism, both in the Myxedema coma and thyroid storm are thyroid nonacute and life-threatening forms of these diseases. emergencies associated with increased mortality. Prompt recognition of these states—which repre- sent the severe, life-threatening conditions of THYROID HORMONE PRODUCTION AND METABOLISM extremely reduced or elevated circulating thyroid hormone concentrations, respectively—is neces- sary to initiate treatment. Management of myxe- The normal physiology of the hypothalamic-pituitary- dema coma and thyroid storm requires both med- thyroid axis involves the production of T4 and T3 by the thyroid gland, a process that is regulated by thyroid- ical and supportive therapies and should be treated stimulating hormone (TSH) secreted by the pituitary, in an intensive care unit setting. which is, in turn, regulated by thyrotropin-releasing hor- Key words: hypothyroidism , hyperthyroidism , mone (TRH) secreted by the hypothalamus. Both serum ICU , myxedema coma , thyroid emergencies , T4 and T3 concentrations act as negative feedback regu- thyroid storm lators of TSH and TRH secretion, but can be altered by environmental conditions—including food availability he thyroid is a 15- to 20-gram gland located and temperature—and disease states, such as infection. 1 in the anterior neck. It is responsible for the Thyroid hormone synthesis is achieved first through production of the thyroid hormones T4 (thy- active transport of circulating iodide, which is taken in roxine) and T3 (triiodothyronine). Various from the diet, by the sodium/iodide symporter located at factors can affect thyroid hormone synthesis, the basolateral membrane of the thyroid follicular cell.
    [Show full text]